Common Stock, Shares, Outstanding of AVADEL PHARMACEUTICALS PLC from 31 Dec 2010 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
AVADEL PHARMACEUTICALS PLC quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2010 to 30 Sep 2025.
  • AVADEL PHARMACEUTICALS PLC Common Stock, Shares, Outstanding for the quarter ending 30 Sep 2025 was 97,235,000, a 0.93% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

AVADEL PHARMACEUTICALS PLC Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 97,235,000 +897,000 +0.93% 30 Sep 2025 10-Q 04 Nov 2025 2025 Q3
Q2 2025 96,777,000 +573,000 +0.6% 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 96,632,000 +535,000 +0.56% 31 Mar 2025 10-Q 07 May 2025 2025 Q1
Q4 2024 96,518,000 +6,693,000 +7.5% 31 Dec 2024 10-Q 04 Nov 2025 2025 Q3
Q3 2024 96,338,000 +6,940,000 +7.8% 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 96,204,000 +6,883,000 +7.7% 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 96,097,000 +31,619,000 +49% 31 Mar 2024 10-Q 08 May 2024 2024 Q1
Q4 2023 89,825,000 +26,947,000 +43% 31 Dec 2023 10-K 03 Mar 2025 2024 FY
Q3 2023 89,398,000 +28,513,000 +47% 30 Sep 2023 10-Q 08 Nov 2023 2023 Q3
Q2 2023 89,321,000 +30,283,000 +51% 30 Jun 2023 10-Q 09 Aug 2023 2023 Q2
Q1 2023 64,478,000 +5,446,000 +9.2% 31 Mar 2023 10-Q 04 May 2023 2023 Q1
Q4 2022 62,878,000 +4,258,000 +7.3% 31 Dec 2022 10-K 29 Feb 2024 2023 FY
Q3 2022 60,885,000 +2,269,000 +3.9% 30 Sep 2022 10-Q 09 Nov 2022 2022 Q3
Q2 2022 59,038,000 +550,000 +0.94% 30 Jun 2022 10-Q 09 Aug 2022 2022 Q2
Q1 2022 59,032,000 +544,000 +0.93% 31 Mar 2022 10-Q 09 May 2022 2022 Q1
Q4 2021 58,620,000 +224,000 +0.38% 31 Dec 2021 10-K 29 Mar 2023 2022 FY
Q3 2021 58,616,000 +373,000 +0.64% 30 Sep 2021 10-Q 08 Nov 2021 2021 Q3
Q2 2021 58,488,000 +359,000 +0.62% 30 Jun 2021 10-Q 09 Aug 2021 2021 Q2
Q1 2021 58,488,000 +21,038,000 +56% 31 Mar 2021 10-Q 10 May 2021 2021 Q1
Q4 2020 58,396,000 +20,876,000 +56% 31 Dec 2020 10-K 16 Mar 2022 2021 FY
Q3 2020 58,243,000 +20,793,000 +56% 30 Sep 2020 10-Q 09 Nov 2020 2020 Q3
Q2 2020 58,129,000 +20,773,000 +56% 30 Jun 2020 10-Q 10 Aug 2020 2020 Q2
Q1 2020 37,450,000 +95,000 +0.25% 31 Mar 2020 10-Q 11 May 2020 2020 Q1
Q4 2019 37,520,000 +207,000 +0.56% 31 Dec 2019 10-K 09 Mar 2021 2020 FY
Q3 2019 37,450,000 +438,000 +1.2% 30 Sep 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 37,356,000 +616,000 +1.7% 30 Jun 2019 10-Q 09 Aug 2019 2019 Q2
Q1 2019 37,355,000 -287,000 -0.76% 31 Mar 2019 10-Q 08 May 2019 2019 Q1
Q4 2018 37,313,000 0 0% 31 Dec 2018 10-K 16 Mar 2020 2019 FY
Q3 2018 37,012,000 -4,423,000 -11% 30 Sep 2018 10-Q 05 Nov 2018 2018 Q3
Q2 2018 36,740,000 -4,695,000 -11% 30 Jun 2018 10-Q 07 Aug 2018 2018 Q2
Q1 2018 37,642,000 -3,738,000 -9% 31 Mar 2018 10-Q 04 May 2018 2018 Q1
Q4 2017 37,313,000 -4,058,000 -9.8% 31 Dec 2017 10-Q 09 Aug 2019 2019 Q2
Q3 2017 41,435,000 +194,000 +0.47% 30 Sep 2017 10-Q 09 Nov 2017 2017 Q3
Q2 2017 41,435,000 +194,000 +0.47% 30 Jun 2017 10-Q 09 Aug 2017 2017 Q2
Q1 2017 41,380,000 +139,000 +0.34% 31 Mar 2017 10-Q 10 May 2017 2017 Q1
Q4 2016 41,371,000 +130,000 +0.32% 31 Dec 2016 10-K 16 Mar 2018 2017 FY
Q3 2016 41,241,000 30 Sep 2016 10-Q 14 Nov 2016 2016 Q3
Q2 2016 41,241,000 +742,236 +1.8% 30 Jun 2016 10-Q 15 Aug 2016 2016 Q2
Q1 2016 41,241,000 +987,986 +2.5% 31 Mar 2016 10-Q 10 May 2016 2016 Q1
Q4 2015 41,241,000 +1,050,000 +2.6% 31 Dec 2015 10-K 28 Mar 2017 2016 FY
Q2 2015 40,498,764 +1,917,464 +5% 30 Jun 2015 6-K 31 Dec 2015 2015 Q2
Q1 2015 40,253,014 +1,985,464 +5.2% 31 Mar 2015 6-K 10 Jul 2015 2015 Q1
Q4 2014 40,191,000 +14,578,450 +57% 31 Dec 2014 10-K 15 Mar 2016 2015 FY
Q3 2014 38,936,300 +13,470,900 +53% 30 Sep 2014 6-K 17 Nov 2014 2014 Q3
Q2 2014 38,581,300 +13,115,900 +52% 30 Jun 2014 6-K 08 Aug 2014 2014 Q2
Q1 2014 38,267,550 31 Mar 2014 6-K 08 Jul 2014 2014 Q1
Q4 2013 25,612,550 +197,150 +0.78% 31 Dec 2013 20-F 01 Oct 2015 2014 FY
Q3 2013 25,465,400 30 Sep 2013 6-K 15 Jan 2014 2013 Q3
Q2 2013 25,465,400 +308,150 +1.2% 30 Jun 2013 6-K 06 Dec 2013 2013 Q2
Q4 2012 25,415,400 +453,150 +1.8% 31 Dec 2012 20-F/A 30 Apr 2014 2013 FY
Q2 2012 25,157,250 30 Jun 2012 6-K 14 Dec 2012 2012 Q2
Q1 2012 25,157,250 31 Mar 2012 6-K 13 Sep 2012 2012 Q1
Q4 2011 24,962,250 +316,600 +1.3% 31 Dec 2011 20-F 30 Apr 2013 2012 FY
Q4 2010 24,645,650 31 Dec 2010 20-F 27 Apr 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.